When the disease is acquired before the age of 65, it is considered as early onset AD (EOAD) and it is associated with mutations in genes coding APP, presenilin-1 (PSEN1), and presenilin-2 (PSEN2) [30]. This evidence concerns the gene PSEN1 and Alzheimer disease.